Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023


ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and nine months ended September 30, 2023 on Tuesday, November 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions.

Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing (844) 868-8846 (U.S.) or (412) 317-5465 (International). A webcast of the call can also be accessed at ENDRA's Investor Relations page and here.

A telephone replay will be available until November 21, 2023 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 4969138. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000 ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic liver spectrum that affects over two billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.


These press releases may also interest you

at 18:18
Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UiPath Inc. ("UiPath" or the "Company") . Class Period: December 1, 2023 ? May 29, 2024 Lead...

at 18:15
Payfare Inc. ("Payfare" or the "Company")  today announces the completion of the filing of its audited annual financial statements, management's discussion and analysis, annual information form and related certifications, all for the year ended...

at 17:53
The Mohanji Foundation, a global non-profit organization founded by Mohanji; World Consciousness Alliance, a Mohanji-founded platform for artists dedicated to raising awareness; and The Diplomatic Club, a non-political, non-profit organization...

at 17:45
The global online home rental services market size is estimated to grow by USD 28.01 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 14.72% during the forecast period. High real estate prices make...

at 17:39
Equity LifeStyle Properties, Inc. (referred to herein as the "Company," "we," "us," and "our") announced today that the Company's second quarter 2024 earnings will be released on Monday, July 22, 2024 after market close. The Company's executive...

at 17:34
The Supreme Court of British Columbia has approved a settlement between Victoria Gold Corp. ("Victoria Gold"), John McConnell, T. Sean Harvey, Michael McInnis, Sean Roosen, Marty Rendall, Orion Co-VI Ltd., BMO Nesbitt Burns Inc., CIBC World Markets...



News published on and distributed by: